Axa S.A. Pliant Therapeutics, Inc. Transaction History

Axa S.A.

$33.1 Billion
Q2 2024

A detailed history of Axa S.A. transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Axa S.A. holds 347,389 shares of PLRX stock, worth $3.93 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

347,389

Previous 347,194 0.06%

Holding current value

$3.93 Million

Previous $5.17 Million 27.82%

% of portfolio

0.01%

Previous 0.02%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$10.58 - $15.61 $2,063 - $3,043	195 Added 0.06%	347,389 $3.73 Million
Q1 2024 May 15, 2024	BUY	$14.14 - $19.59 $1,329 - $1,841	94 Added 0.03%	347,194 $5.17 Million
Q4 2023 Jul 16, 2024	SELL	$12.85 - $19.15 $1,207 - $1,800	-94 Reduced 0.03%	347,100 $6.29 Million
Q4 2023 Feb 14, 2024	SELL	$12.85 - $19.15 $107,901 - $160,802	-8,397 Reduced 2.36%	347,100 $6.29 Million
Q3 2023 Nov 14, 2023	BUY	$14.58 - $20.15 $1.45 Million - $2 Million	99,218 Added 38.71%	355,497 $6.16 Million
Q2 2023 Aug 14, 2023	BUY	$18.12 - $30.56 $321,285 - $541,859	17,731 Added 7.43%	256,279 $4.64 Million
Q1 2023 May 15, 2023	SELL	$18.73 - $36.26 $634,104 - $1.23 Million	-33,855 Reduced 12.43%	238,548 $6.35 Million
Q4 2022 Feb 14, 2023	SELL	$17.0 - $25.43 $441,915 - $661,052	-25,995 Reduced 8.71%	272,403 $5.27 Million
Q3 2022 Feb 14, 2023	SELL	$7.67 - $24.23 $288,392 - $911,048	-37,600 Reduced 11.19%	298,398 $6.23 Million
Q3 2022 Nov 14, 2022	SELL	$7.67 - $24.23 $288,392 - $911,048	-37,600 Reduced 11.19%	298,398 $6.23 Million
Q2 2022 Feb 14, 2023	BUY	$4.11 - $8.75 $3,970 - $8,452	966 Added 0.29%	335,998 $2.69 Million
Q2 2022 Aug 15, 2022	BUY	$4.11 - $8.75 $3,970 - $8,452	966 Added 0.29%	335,998 $2.69 Million
Q1 2022 Feb 14, 2023	BUY	$7.01 - $14.1 $256,804 - $516,539	36,634 Added 12.28%	335,032 $2.35 Million
Q1 2022 May 13, 2022	BUY	$7.01 - $14.1 $2.35 Million - $4.72 Million	335,032 New	335,032 $2.35 Million

Others Institutions Holding PLRX

# of Institutions

158

Shares Held

63.8M

Call Options Held

481K

Put Options Held

105K

View Full List

About PLIANT THERAPEUTICS, INC.

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $551M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

More about PLRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Account